2006
DOI: 10.1089/hum.2006.17.1006
|View full text |Cite
|
Sign up to set email alerts
|

HyperactiveHimar1Transposase Mediates Transposition in Cell Culture and Enhances Gene ExpressionIn Vivo

Abstract: The use of nonviral delivery systems results in transient gene expression, in part because of the low efficiency of DNA integration. Previously, vectors based on transposon systems such as Sleeping Beauty have been shown to be able to increase stable transfection efficiencies in cell culture and in animal models. Himar1, a reconstructed active transposon belonging to the Tc1/mariner superfamily, also has been used as a vector for stable gene delivery, but the rate of transposition after transfection is low. In… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
22
0

Year Published

2007
2007
2015
2015

Publication Types

Select...
8
2

Relationship

0
10

Authors

Journals

citations
Cited by 29 publications
(22 citation statements)
references
References 36 publications
0
22
0
Order By: Relevance
“…This element has been shown to be active in a number of animals, including mammals [52,53]. Hyperactive variants have been developed as well [54]. How this element quantitatively compares to other members of this family in vertebrate applications is still largely unknown.…”
Section: Himar1mentioning
confidence: 99%
“…This element has been shown to be active in a number of animals, including mammals [52,53]. Hyperactive variants have been developed as well [54]. How this element quantitatively compares to other members of this family in vertebrate applications is still largely unknown.…”
Section: Himar1mentioning
confidence: 99%
“…The Sleeping Beauty transposon system represents an increasingly important vehicle for in vivo gene delivery. At present, however, much of the effort directed towards successfully adapting this and other DNA transposons to a clinical setting have focused to a large extent on obtaining improved integration frequencies in target cells via mutation of transposon (donor) and/or transposase (helper) components (1,13,27,60,64). Our work presented herein suggests that SB's integration efficiency may not be as great a barrier as previously thought and implies that a greater emphasis on postintegrative regulatory mechanisms may ultimately prove more productive in perfecting SB for a clinical environment.…”
Section: Vol 27 2007 Transposon Silencing In Mammals 8829mentioning
confidence: 99%
“…There is currently work being done with PB transposase to increase the transpositional efficiencies to that of retroviral vectors. There are methods to accomplish this goal such as PCR random mutagenesis or alanine substitutions utilizing mutagenic PCR primers (Goryshin and Reznikoff 1998;Yant et al 2004;Pledger and Coates 2005;Keravala et al 2006). One of us, Thomas Ryan, is pursuing PB active transgenesis in embryonic stem cells for the production of transgenic animals.…”
Section: Mechanisms To Improve Specificity and Efficiency Of Transfecmentioning
confidence: 99%